In a press release issued Tuesday, December 7, the U.S. Centers for Disease Control and Prevention (CDC) announced the launch of two global networks to address the rise of antimicrobial resistance and other healthcare threats.
Dr. Bollinger: “My own expectation is that being fully vaccinated, including boosters, will still provide a reduced risk of hospitalization and death."
India is the world’s leading consumer of antibiotics, and Amita Gupta, MD, is researching how the country can best mitigate the spread of antimicrobial resistance.
Dr. Akshay Gupte and colleagues discovered that elevated IL-6 can predict poor treatment outcomes, showcasing a need for including IL-6 in clinical screenings.
Gauri Dhumal and Neetal Nevrekar received the award from USAID’s Women in Science Mentoring Program for separate pilot projects that study better tuberculosis treatment methods. Nishi Suryavanshi is their mentor.
Last spring, India experienced a catastrophic wave of COVID-19 infections with more than 100,000 cases per day, exceeding hospital capacity in some areas and leading to oxygen shortages.
“If we can screen patients early and get their household contacts on preventive therapy, we have an opportunity to stop the chain of this horrible disease.”
